In the BioHarmony Drug Report Database
Lorazepam
Ativan, Loreev (lorazepam) is a small molecule pharmaceutical. Lorazepam was first approved as Ativan on 1982-01-01. It is used to treat anxiety disorders, catatonia, depressive disorder, partial epilepsies, and psychotic disorders amongst others in the USA. It is known to target Alpha-1B adrenergic receptor and ovarian cancer G-protein coupled receptor 1.
Trade Name
|
Ativan, Loreev |
|---|---|
Common Name
|
lorazepam |
ChEMBL ID
|
CHEMBL580 |
Indication
|
anxiety disorders, catatonia, depressive disorder, partial epilepsies, psychotic disorders, sleep initiation and maintenance disorders, status epilepticus, substance withdrawal syndrome, vomiting |
Drug Class
|
Antianxiety agents (diazepam type) |
Image (chem structure or protein)